Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

oxyMORphone

oxyMORphone
  • Non-formulary Narcotic - Oral
  • Non-formulary Oral oxyMORphone interchange was updated to oxyCODONE from morphine in May 2017.
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Numorphan HCl SOLUTION, INJECTABLE 1 mg/mL, 1.5 mg/mL    
Opana ER TABLET, EXTENDED RELEASE, ORAL 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg    
Opana TABLET, ORAL 5 mg, 10 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

oxyMORphone (Opana IR)

  • 5 mg q6h
  • 5 mg q4h
  • 10 mg q6h
  • 10 mg q4h

oxyCODONE IR (Roxicodone)

  • 10 mg q6h
  • 10 mg q4h
  • 15 mg q4h
  • two 15 mg (Total: 30 mg) q6h

oxyMORphone (Opana ER)

  • 5 mg ER BID
  • 7.5 mg ER BID
  • 10 mg ER BID
  • 15 mg ER BID
  • 20 mg ER BID
  • 30 mg ER BID
  • 40 mg ER BID

oxyCODONE ER (OxyCONTIN)

  • 10 mg ER tab q12h (Total: 20 mg/day)
  • 15 mg ER tab q12h (Total: 30 mg/day)
  • 20 mg ER tab q12h (Total: 40 mg/day)
  • two 15 mg ER tab q12h (Total: 60 mg/day)
  • 40 mg ER tab q12h (Total: 80 mg/day)
  • 40 mg ER tab q8h (Total: 120 mg/day)
  • 80 mg ER tab q12h (Total: 160 mg/day)

Opana ER medication guide

Reviewed: September 26, 2006, and September 23, 2008, and October 26, 2010, and 23 May 2017 (Opana IR and ER)

REMS (Opana ER): View FDA REMS Info

Last updated: Jan. 16, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved